Transforming properties of the leukemic Inv(16) fusion gene CBFB-MYH11

Current Topics in Microbiology and Immunology

Volumn 211, Issue , 1996, Pages 289-298

  Hajra, A ^a   Liu, P P ^a   Collins, F S ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MYOSIN;

ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME 16; CHROMOSOME INVERSION; CONFERENCE PAPER; EOSINOPHILIA; GENE EXPRESSION; HUMAN; ONCOGENE; PRIORITY JOURNAL;

EID: 0030064340     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85232-9_29     Document Type: Conference Paper

References (23)

1. Bae S-C, Ogawa E, Maruyama M, Oka H, Satake M, Shigesada K, Jenkins NA, Gilbert DJ, Copeland NG, Ito Y (1994) PEBP2αB/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol 14:3242-3252
2. Hajra A, Collins F S (1995) Structure of the leukemia-associated human CBFB gene. Genomics 26:571-579
3. Hajra A, Liu PP, Wang Q, Kelley CA, Stacy T, Adelstein RS, Speck NA, Collins FS (1995) The leukemic core binding factor β-smooth muscle myosin heavy chain (CBFβ-SMMHC) chimeric protein requires both CBFβ and myosin heavy chain domains for transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 92:1926-1930
4. Hajra A, Liu PP, Speck NA, Collins FS Overexpression of CBFa reverses cellular transformation by the CBFβ-SMMHC chimeric oncoprotein. Mol Cell Biol in press
5. Hernandez-Munain C and Krangel MS (1995) c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor δ enhancer. Mol Cell Biol 15:3090-3099
6. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P (1993) The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet 9:338-341
7. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y (1994) AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432
8. Liu P, Tarlé SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS (1993) Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 261:1041-1044
9. Liu P, Seidel N, Bodine D, Speck N, Tarlé S, Collins FS (1994) Acute myeloid leukemia with inv(16) produces a chimeric transcription factor with a myosin heavy chain tail. Cold Spring Harbor Symp.Quant.Biol 59:547-553
10. Liu PP, Hajra A, Wijmenga C, Collins FS (1995) Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of AML. Blood 85:2289-2302
11. Lu J, Maruyama M, Satake M, Bae S-C, Ogawa E, Kagoshima H, Shigesada K, Ito Y (1995) Subcellular localization of the α and β subunits of acute myeloid leuekmia-linked transcription factor PEBP2/CBF. Mol Cell Biol 15:1651-1661
12. Matsuoka R, Yoshida MC, Furutani Y, Imamura S, Kanda N, Yanagisawa M, Masaki T, Takao A (1993) Human smooth muscle heavy chain gene mapped to chromosomal region 16q12. Am J Med Genet 46:61-67
13. Meyers S, Lenny N, Hiebert SW (1995) The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol 15:1974-1982
14. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H (1994) Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504-510
15. Morano DL (1992) Molecular biology of smooth muscle. J Hypertens 10:411-416
16. Nucifora G, Begy CR, Kobyashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) transloactions. Proc Natl Acad Sci USA 91:4004-4008
17. Nucifora G, Rowley JD (1994) The AML1 and ETO genes in acute myeloid leukemia with a t(8;21) Leuk Lymphoma 14:353-362
18. Ogawa E, Inuzuka M, Maruyama M, Statke M, Naito-Fujimoto M, Ito Y, Shigesada K (1993a) Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virology 194:314-331
19. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y (1993b) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90:6859-6863
20. Shurtleff SA, Meyers S, Hiebert SW, Raimondi SC, Head DR, Willman CL, Wolman S, Carroll AJ, Behm F, Hulshof MG, Motroni TA, Liu P, Collins FS, Downing JR Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) translocation in acute myelogenous leukemia. Blood in press
21. Sun W, Graves BJ, Speck NA Transactivation of the Moloney murine leukemia virus and T cell receptor β chain enhancers by CBF and Ets requires intact binding sites for both proteins. J Virol in press
22. Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA (1993) Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol Cell Biol 13:3324-3339
23. Wotton D, Ghysdael J, Wang S, Speck NA, Owen, MJ (1994) Cooperative binding of Ets-1 and Core Binding Factor to DNA. Mol Cell Biol 14:840-850